May. 14 at 8:41 PM
$STE Steris sees FY26 adjusted EPS
$9.90-
$10.15, consensus
$9.88
Sees FY26 revenue up 6%-7%. The company said, "For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 6-7%. Based on forward rates through March 31, 2026, currency is expected to be neutral to revenue in fiscal 2026. As a result, constant currency organic revenue growth from continuing operations is also anticipated to be 6-7%.
Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of
$9.90 to
$10.15, an increase of 7-10% compared with
$9.22 in adjusted earnings per diluted share from continuing operations in fiscal 2025. Included in this outlook is the negative impact of tariffs, estimated to reduce pre-tax profit by approximately
$30 million. Capital expenditures are anticipated to be approximately
$375 million and free cash flow is expected to be approximately
$770 million."
